Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'TOPOISOMERASE-I' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1443 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Simbulan-Rosenthal, CM; Rosenthal, DS; Luo, RB; Samara, R; Jung, M; Dritschilo, A; Spoonde, A; Smulson, ME
      Poly(ADP-ribosyl)ation of p53 in vitro and in vivo modulates binding to its DNA consensus sequence

      NEOPLASIA
    2. Streltsov, S; Sukhanova, A; Mikheikin, A; Grokhovsky, S; Zhuze, A; Kudelina, I; Mochalov, K; Oleinikov, V; Jardillier, JC; Nabiev, I
      Structural basis of Topotecan-DNA recognition probed by flow linear dichroism, circular dichroism, and Raman spectroscopy

      JOURNAL OF PHYSICAL CHEMISTRY B
    3. Harayama, T; Akamatsu, H; Okamura, K; Miyagoe, T; Akiyama, T; Abe, H; Takeuchi, Y
      Synthesis of trisphaeridine and norchelerythrine through palladium-catalyzed aryl-aryl coupling reaction

      JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1
    4. Czuwara-Ladykowska, J; Makiela, B; Smith, EA; Trojanowska, M; Rudnicka, L
      The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis

      ARTHRITIS RESEARCH
    5. Sato, S; Hamaguchi, Y; Hasegawa, M; Takehara, K
      Clinical significance of anti-topoisomerase I antibody levels determined by ELISA in systemic sclerosis

      RHEUMATOLOGY
    6. Tasara, T; Hottiger, MO; Hubscher, U
      Functional genomics in HIV-1 virus replication: Protein-protein interactions as a basis for recruiting the host cell machinery for viral propagation

      BIOLOGICAL CHEMISTRY
    7. Lebel, M
      Werner syndrome: genetic and molecular basis of a premature aging disorder

      CELLULAR AND MOLECULAR LIFE SCIENCES
    8. Oguma, T
      Antitumor drugs possessing topoisomerase I inhibition: applicable separation methods

      JOURNAL OF CHROMATOGRAPHY B
    9. Palumbo, M; Sissi, C; Gatto, B; Moro, S; Zagotto, G
      Quantitation of camptothecin and related compounds

      JOURNAL OF CHROMATOGRAPHY B
    10. Zufia, L; Aldaz, A; Giraldez, J
      Separation methods for camptothecin and related compounds

      JOURNAL OF CHROMATOGRAPHY B
    11. Smith, JA; Hausheer, F; Newman, RA; Madden, TL
      Development of a high-performance liquid chromatographic method to determine the concentration of karenitecin, a novel highly lipophilic camptothecinderivative, in human plasma and urine

      JOURNAL OF CHROMATOGRAPHY B
    12. Jung, LL; Zamboni, WC
      Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?

      DRUG RESISTANCE UPDATES
    13. Duffy, JY; Miller, CM; Rutschilling, GL; Ridder, GM; Clegg, MS; Keen, CL; Daston, GP
      A decrease in intracellular zinc level precedes the detection of early indicators of apoptosis in HL-60 cells

      APOPTOSIS
    14. Sakamoto, S; Nishikawa, K; Heo, SJ; Coto, M; Furuichi, Y; Shimamoto, A
      Werner helicase relocates into nuclear foci in response to DNA damaging agents and co-localizes with RPA and Rad51

      GENES TO CELLS
    15. Balestrazzi, A; Bernacchia, G; Pitto, L; Luccarini, G; Carbonera, D
      Spatial expression of DNA topoisomerase I genes during cell proliferation in Daucus carota

      EUROPEAN JOURNAL OF HISTOCHEMISTRY
    16. Leichman, L; Leichman, CG
      Therapy of disseminated colorectal cancer: The emerging role of intratumoral molecular biology

      EUROPEAN JOURNAL OF SURGERY
    17. Takebayashi, Y; Pourquier, P; Zimonjic, DB; Nakayama, K; Emmert, S; Ueda, T; Urasaki, Y; Kanzaki, A; Akiyama, S; Popescu, N; Kraemer, KH; Pommier, Y
      Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair

      NATURE MEDICINE
    18. Mathijssen, RHJ; van Alphen, RJ; Verweij, J; Loos, WJ; Nooter, K; Stoter, G; Sparreboom, A
      Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)

      CLINICAL CANCER RESEARCH
    19. Zamboni, WC; D'Argenio, DZ; Stewart, CF; MacVittie, T; Delauter, BJ; Farese, AM; Potter, DM; Kubat, NM; Tubergen, D; Egorin, MJ
      Pharmacodynamic model of topotecan-induced time course of neutropenia

      CLINICAL CANCER RESEARCH
    20. Maliepaard, M; van Gastelen, MA; Tohgo, A; Hausheer, FH; van Waardenburg, RCAM; de Jong, LA; Pluim, D; Beijnen, JH; Schellens, JHM
      Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918

      CLINICAL CANCER RESEARCH
    21. Kirstein, MN; Houghton, PJ; Cheshire, PJ; Richmond, LB; Smith, AK; Hanna, SK; Stewart, CF
      Relation between 9-aminocamptothecin systemic exposure and tumor response in human solid tumor xenografts

      CLINICAL CANCER RESEARCH
    22. Minami, H; Fujii, H; Igarashi, T; Itoh, K; Tamanoi, K; Oguma, T; Sasaki, Y
      Phase I and pharmacological study of a new camptothecin derivative, exatecan mesylate (DX-8951f), infused over 30 minutes every three weeks

      CLINICAL CANCER RESEARCH
    23. Guichard, S; Montazeri, A; Chatelut, E; Hennebelle, I; Bugat, R; Canal, P
      Schedule-dependent activity of topotecan in OVCAR-3 ovarian carcinoma xenograft: Pharmacokinetic and pharmacodynamic evaluation

      CLINICAL CANCER RESEARCH
    24. Jagasia, MH; Langer, CJ; Johnson, DH; Yunus, F; Rodgers, JS; Schlabach, LL; Cohen, AG; Shyr, Y; Carbone, DP; DeVore, RF
      Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: A multicenter phase II study

      CLINICAL CANCER RESEARCH
    25. Li, ML; Horn, L; Firby, PS; Moore, MJ
      Pharmacological determinants of 9-aminocamptothecin cytotoxicity

      CLINICAL CANCER RESEARCH
    26. Scaldaferro, S; Tinelli, S; Borgnetto, ME; Azzini, A; Capranico, G
      Directed evolution to increase camptothecin sensitivity of human DNA topoisomerase I

      CHEMISTRY & BIOLOGY
    27. Makinsky, AA; Kritzyn, AM; Ul'yanova, EA; Zakharova, OD; Bugreev, DV; Nevinsky, GA
      Polymethylene derivatives of nucleic bases with omega-functional groups: II. Adenine and hypoxanthine derivatives

      RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY
    28. Shav-Tal, Y; Cohen, M; Lapter, S; Dye, B; Patton, JG; Vandekerckhove, J; Zipori, D
      Nuclear relocalization of the pre-mRNA splicing factor PSF during apoptosis involves hyperphosphorylation, masking of antigenic epitopes, and changesin protein interactions

      MOLECULAR BIOLOGY OF THE CELL
    29. Pichierri, P; Franchitto, A; Mosesso, P; Palitti, F
      Werner's syndrome protein is required for correct recovery after replication arrest and DNA damage induced in S-phase of cell cycle

      MOLECULAR BIOLOGY OF THE CELL
    30. Van Duyne, GD
      A structural view of Cre-loxP site-specific recombination

      ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE
    31. Seiter, K; Liu, DL; Feldman, EJ; Siddiqui, AD; Hoang, A; Baskind, P; Kancherla, R; Ahmed, T
      Intravenous bolus topotecan in patients with myelodysplastic syndrome

      LEUKEMIA & LYMPHOMA
    32. Takagi, T; Saotome, T
      Chemotherapy with irinotecan (CPT-11), a topoisomerase-I inhibitor, for refractory and relapsed non-Hodgkin's lymphoma

      LEUKEMIA & LYMPHOMA
    33. Platzer, P; Thalhammer, T; Reznicek, G; Hamilton, G; Zhang, RW; Jager, W
      Metabolism and biliary excretion of the novel anticancer agent 10-hydroxycamptothecin in the isolated perfused rat liver

      INTERNATIONAL JOURNAL OF ONCOLOGY
    34. Redkar, AA; Meadows, GG; Daoud, SS
      UCN-01 dose-dependent inhibition of normal hyperproliferative cells in mice

      INTERNATIONAL JOURNAL OF ONCOLOGY
    35. Lu, CB; Fu, WM; Mattson, MP
      Caspase-mediated suppression of glutamate (AMPA) receptor channel activityin hippocampal neurons in response to DNA damage promotes apoptosis and prevents necrosis: Implications for neurological side effects of cancer therapy and neurodegenerative disorders

      NEUROBIOLOGY OF DISEASE
    36. Xiong, WN; Yang, CG; Jiang, B
      Synthesis of novel analogues of marine indole alkaloids: Mono(indolyl)-4-trifluoromethylpyridines and bis(indolyl)-4-trifluoromethylpyridines as potential anticancer agents

      BIOORGANIC & MEDICINAL CHEMISTRY
    37. Aubert, Y; Perrouault, L; Helene, C; Giovannangeli, C; Asseline, U
      Synthesis and properties of triple helix-forming oligodeoxyribonucleotidescontaining 7-chloro-7-deaza-2 '-deoxyguanosine

      BIOORGANIC & MEDICINAL CHEMISTRY
    38. Jiang, B; Yang, CG; Xiong, WN; Wang, J
      Synthesis and cytotoxicity evaluation of novel indolylpyrimidines and indolylpyrazines as potential antitumor agents

      BIOORGANIC & MEDICINAL CHEMISTRY
    39. Voldoire, A; Sancelme, M; Prudhomme, M; Colson, P; Houssier, C; Bailly, C; Leonce, S; Lambel, S
      Rebeccamycin analogues from indolo[2,3-c] carbazole

      BIOORGANIC & MEDICINAL CHEMISTRY
    40. Deady, LW; Desneves, J; Kaye, AJ; Finlay, GJ; Baguley, BC; Denny, WA
      Positioning of the carboxamide side chain in 11-oxo-11H-indeno[1,2-b]quinolinecarboxamide anticancer agents: Effects on cytotoxicity

      BIOORGANIC & MEDICINAL CHEMISTRY
    41. Jiang, B; Xiong, XN; Yang, CG
      Synthesis and antitumor evaluation of novel monoindolyl-4-trifluoromethylpyridines and bisindolyl-4-trifluoromethylpyridines

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    42. Dallavalle, S; Ferrari, A; Merlini, L; Penco, S; Carenini, N; De Cesare, M; Perego, P; Pratesi, G; Zunino, F
      Novel cytotoxic 7-iminomethyl and 7-aminomethyl derivatives of camptothecin

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    43. Slater, MJ; Baxter, R; Bonser, RW; Cockerill, S; Gohil, K; Parry, N; Robinson, E; Randall, R; Yeates, C; Snowden, W; Walters, A
      Synthesis of N-alkyl substituted indolocarbazoles as potent inhibitors of human cytomegalovirus replication

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    44. Boucard, M; Pinguet, F; Poujol, S; Romieu, G; Cupissol, D; Astre, C; Culine, S; Bressolle, F
      Salivary and plasma pharmacokinetics of topotecan in patients with metastatic epithelial ovarian cancer

      EUROPEAN JOURNAL OF CANCER
    45. Oka, M; Fukuda, M; Fukuda, M; Kinoshita, A; Kuba, M; Ichiki, M; Rikimaru, T; Soda, H; Takatani, H; Narasaki, F; Nagashima, S; Nakamura, YI; Hayashi, N; Kohno, S
      Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in unresectable and locally advanced non-small cell lung cancer

      EUROPEAN JOURNAL OF CANCER
    46. Guichard, S; Arnould, S; Hennebelle, I; Bugat, R; Canal, P
      Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activity in vitro and in vivo

      ANTI-CANCER DRUGS
    47. Yamamoto, W; Verweij, J; de Bruijn, P; de Jonge, MJA; Takano, H; Nishiyama, M; Kurihara, M; Sparreboom, A
      Active transepithelial transport of irinotecan (CPT-11) and its metabolites by human intestinal Caco-2 cells

      ANTI-CANCER DRUGS
    48. Stewart, AJ; Mistry, P; Dangerfield, W; Bootle, D; Baker, M; Kofler, B; Okiji, S; Baguley, BC; Denny, WA; Charlton, PA
      Antitumor activity of XR5944, a novel and potent topoisomerase poison

      ANTI-CANCER DRUGS
    49. Kehrer, DFS; Soepenberg, O; Loos, WJ; Verweij, J; Sparreboom, A
      Modulation of camptothecin analogs in the treatment of cancer: a review

      ANTI-CANCER DRUGS
    50. Demarquay, D; Huchet, M; Coulomb, H; Lesueur-Ginot, L; Lavergne, O; Kasprzyk, PG; Bailly, C; Camara, J; Bigg, DCH
      The homocamptothecin BN 80915 is a highly potent orally active topoisomerase I poison

      ANTI-CANCER DRUGS
    51. Cordell, GA; Quinn-Beattie, ML; Farnsworth, NR
      The potential of alkaloids in drug discovery

      PHYTOTHERAPY RESEARCH
    52. Karayan, L; Riou, JF; Seite, P; Migeon, J; Cantereau, A; Larsen, CJ
      Human ARF protein interacts with Topoisomerase I and stimulates its activity

      ONCOGENE
    53. Shao, RG; Cao, CX; Nieves-Neira, W; Dimanche-Boitrel, MT; Solary, E; Pommier, Y
      Activation of the Fas pathway independently of Fas ligand during apoptosisinduced by camptothecin in p53 mutant human colon carcinoma cells

      ONCOGENE
    54. Niitsu, N; Iijima, K; Chizuka, A
      Combination therapy with irinotecan (CPT-11), mitoxantrone, and dexamethasone in relapsed or refractory non-Hodgkin's lymphoma: a pilot study

      ANNALS OF HEMATOLOGY
    55. Alberts, SR; Erlichman, C; Sloan, J; Okuno, SH; Burch, PA; Rubin, J; Pitot, HC; Goldberg, RM; Adjei, AA; Atherton, PJ; Kaufmann, SH
      Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks

      ANNALS OF ONCOLOGY
    56. Sanz-Altamira, PM; O'Reilly, E; Stuart, KE; Raeburn, L; Steger, C; Kemeny, NE; Saltz, LB
      A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma

      ANNALS OF ONCOLOGY
    57. Rothenberg, ML; Kuhn, JG; Schaaf, LJ; Rodriguez, GI; Eckhardt, SG; Villalona-Calero, MA; Rinaldi, DA; Hammond, LA; Hodges, S; Sharma, A; Elfring, GL; Petit, RG; Locker, PK; Miller, LL; von Hoff, DD
      Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks

      ANNALS OF ONCOLOGY
    58. Saita, T; Fujito, H; Mori, M
      Determination of topotecan by ELISA

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    59. Kinuya, K; Nakajima, K; Kinuya, S; Michigishi, T; Tonami, N; Takehara, K
      Esophageal hypomotility in systemic sclerosis: Close relationship with pulmonary involvement

      ANNALS OF NUCLEAR MEDICINE
    60. Rich, TA; Kirichenko, AV
      Camptothecin schedule and timing of administration with irradiation

      ONCOLOGY-NEW YORK
    61. O'Reilly, EM; Ilson, DH
      Cisplatin and irinotecan in upper gastrointestinal malignancies

      ONCOLOGY-NEW YORK
    62. Gonzalez, IL; Sylvester, JE
      Human rDNA: Evolutionary patterns within the genes and tandem arrays derived from multiple chromosomes

      GENOMICS
    63. Dowlati, A; Hoppel, CL; Ingalls, ST; Majka, S; Li, XL; Sedransk, N; Spiro, T; Gerson, SL; Ivy, P; Remick, SC
      Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive days

      JOURNAL OF CLINICAL ONCOLOGY
    64. Royce, ME; Hoff, PM; Dumas, P; Lassere, Y; Lee, JJ; Coyle, J; Ducharme, MP; De Jager, R; Pazdur, R
      Phase I and pharmacokinetic study of exatecan mesylate (DX-8951f): A novelcamptothecin analog

      JOURNAL OF CLINICAL ONCOLOGY
    65. Vanhoefer, U; Harstrick, A; Achterrath, W; Cao, SS; Seeber, S; Rustum, YM
      Irinotecan in the treatment of colorectal cancer: Clinical overview

      JOURNAL OF CLINICAL ONCOLOGY
    66. Socinski, MA; Sandler, AB; Miller, LL; Locker, PK; Hanover, CK; Elfring, GL; Israel, VK; Pirotta, N; Natale, RB
      Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    67. Fisher, BJ; Scott, C; Macdonald, DR; Coughlin, C; Curran, WJ
      Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: Results of Radiation Therapy Oncology Group Trial 9507

      JOURNAL OF CLINICAL ONCOLOGY
    68. Clarke-Pearson, DL; Van Le, L; Iveson, T; Whitney, CW; Hanjani, P; Kristensen, G; Malfetano, JH; Beckman, RA; Ross, GA; Lane, SR; DeWitte, MH; Fields, SZ
      Oral topotecan as single-agent second-line chemotherapy in patients with advanced ovarian cancer

      JOURNAL OF CLINICAL ONCOLOGY
    69. Pagano, L; Mele, L; Voso, MT; Chiusolo, P; Putzulu, R; Mazzotta, S; Leone, G
      The association of topotecan and cytarabine in the treatment of secondary or relapsed acute myeloid leukemia

      HAEMATOLOGICA
    70. Smith, SF; Metcalfe, JA; Elgar, G
      Characterisation of two topoisomerase 1 genes in the pufferfish (Fugu rubripes)

      GENE
    71. Biswas, A; Dey, J
      Ground and excited-state ionization behavior of 9-aminocamptothecin: An absorption and fluorescence spectral study

      INDIAN JOURNAL OF CHEMISTRY SECTION A-INORGANIC BIO-INORGANIC PHYSICAL THEORETICAL & ANALYTICAL CHEMISTRY
    72. Das, B; Madhusudhan, P; Reddy, PV; Anitha, Y
      Natural camptothecins

      INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY
    73. Shigeoka, Y; Itoh, K; Igarashi, T; Ishizawa, K; Saeki, T; Fujii, H; Minami, H; Imoto, S; Sasaki, Y
      Clinical effect of irinotecan in advanced and metastatic breast cancer patients previously treated with doxorubicin- and docetaxel-containing regimens

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    74. Stadler, M; Bauch, F; Henkel, T; Muhlbauer, A; Muller, H; Spaltmann, F; Weber, K
      Antifungal actinomycete metabolites discovered in a differential cell-based screening using a recombinant TOPO1 deletion mutant strain

      ARCHIV DER PHARMAZIE
    75. Kim, Y; You, YJ; Ahn, BZ
      Naphthazarin derivatives (VIII): Synthesis, inhibitory effect on DNA topoisomerase-I, and antiproliferative activity of 6-(1-acyloxyalkyl)-5,8-dimethoxy-1,4-naphthoquinones

      ARCHIV DER PHARMAZIE
    76. Lee, ST; Jang, JH; Suh, HC; Hahn, JS; Ko, YW; Min, YH
      Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome

      AMERICAN JOURNAL OF HEMATOLOGY
    77. Canalle, R; Burim, RV; Lopes, JLC; Takahashi, CS
      Assessment of the cytotoxic and clastogenic activities of the sesquiterpene lactone lychnopholide in mammalian cells in vitro and in vivo

      CANCER DETECTION AND PREVENTION
    78. Chastagner, P; Kozin, SV; Taghian, A
      Topotecan selectively enhances the radioresponse of human small-cell lung carcinoma and glioblastoma multiforme xenografts in nude mice

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    79. Konstadoulakis, MM; Antonakis, PT; Tsiblouis, BG; Stathopoulos, GP; Manouras, AP; Mylonaki, DB; Golematis, BX
      A phase II study of 9-nitrocamptothecin in patients with advanced pancreatic adenocarcinoma

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    80. Bahadori, HR; Green, MR; Catapano, CV
      Synergistic interaction between topotecan and microtubule-interfering agents

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    81. Thomas, RR; Dahut, W; Harold, N; Grem, JL; Monahan, BP; Liang, M; Band, RA; Cottrell, J; Llorens, V; Smith, JA; Corse, W; Arbuck, SG; Wright, J; Chen, AP; Hamilton, JM; Allegra, CJ; Takimoto, CH
      A phase I and pharmacologic study of 9-aminocamptothecin administered as a120-h infusion weekly to adult cancer patients

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    82. Cavazos, CM; Keir, ST; Yoshinari, T; Bigner, DD; Friedman, HS
      Therapeutic activity of the topoisomerase I inhibitor J-107088 [6-N-(1-hydroxymethyla-2-hydroxy) ethylamino-12,13-dihydro-13-(beta-D-gluco pyranosyl)5H-indolo[2,3-a]-pyrrolo[3,4-c]-carbazole-5,7(6H)-dione] against pediatric and adult central nervous system tumor xenografts

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    83. Ling, YH; Donato, NJ; Perez-Soler, R
      Sensitivity to topoisomerase I inhibitors and cisplatin is associated withepidermal growth factor receptor expression in human cervical squamous carcinoma ME180 sublines

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    84. Dowlati, A; Levitan, N; Gordon, NH; Hoppel, CL; Gosky, DM; Remick, SC; Ingalls, ST; Berger, SJ; Berger, NA
      Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    85. Herrington, JD; Figueroa, JA; Kirstein, MN; Zamboni, WC; Stewart, CF
      Effect of hemodialysis on topotecan disposition in a patient with severe renal dysfunction

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    86. Nietert, PJ; Silverstein, MD; Silver, RM
      Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis

      JOURNAL OF RHEUMATOLOGY
    87. Kang, SH; Park, MH; Song, EY; Kang, SJ; Lee, EB; Song, YW; Takeuchi, F
      Association of HLA class II genes with systemic sclerosis in Koreans

      JOURNAL OF RHEUMATOLOGY
    88. Jacobsen, S; Ullman, S; Shen, GQ; Wiik, A; Halberg, P
      Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis

      JOURNAL OF RHEUMATOLOGY
    89. Kozerski, L; Mazurek, AP; Kawecki, R; Bocian, W; Krajewski, P; Bednarek, E; Sitkowski, J; Williamson, MP; Moir, AJG; Hansen, PE
      A nicked duplex decamer DNA with a PEG(6) tether

      NUCLEIC ACIDS RESEARCH
    90. Kim, SH; Kang, IC; Yoon, TJ; Park, YM; Kang, KS; Song, GY; Ahn, BZ
      Antitumor activities of a newly synthesized shikonin derivative, 2-hyim-DMNQ-S-33

      CANCER LETTERS
    91. Scheirer, KE; Higgins, NP
      Transcription induces a supercoil domain barrier in bacteriophage Mu

      BIOCHIMIE
    92. Nordstrom, K; Dasgupta, S
      Partitioning of the Escherichia coli chromosome: Superhelicity and condensation

      BIOCHIMIE
    93. Oberto, J; Rouviere-Yaniv, J
      Does the parallel evolution pattern between the replication-segregation proteins and HU have a biological significance?

      BIOCHIMIE
    94. Huntington, MO; Krell, KE; Armour, WE; Liljenquist, JE
      Temporary reversal by topotecan of marked insulin resistance in a patient with myelodysplastic syndrome - Case report and possible mechanism for tumor necrosis factor alpha (TNF-alpha)-induced insulin resistance

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    95. Allemand, E; Gattoni, R; Bourbon, HM; Stevenin, J; Caceres, JF; Soret, J; Tazi, J
      Distinctive features of Drosophila alternative splicing factor RS domain: Implication for specific phosphorylation, shuttling, and splicing activation

      MOLECULAR AND CELLULAR BIOLOGY
    96. Chavez, S; Garcia-Rubio, M; Prado, F; Aguilera, A
      Hpr1 is preferentially required for transcription of either long or G+C-Rich DNA sequences in Saccharomyces cerevisiae

      MOLECULAR AND CELLULAR BIOLOGY
    97. Burim, RV; Canalle, R; Lopes, JLC; Vichnewski, W; Takahashi, CS
      Genotoxic action of the sesquiterpene lactone centratherin on mammalian cells in vitro and in vivo

      TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS
    98. Topcu, Z
      DNA topoisomerases as targets for anticancer drugs

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    99. Neidle, S
      DNA minor-groove recognition by small molecules

      NATURAL PRODUCT REPORTS
    100. Helleday, T; Johansson, F; Jenssen, D
      The DRAG test: an assay for detection of genotoxic damage

      ATLA-ALTERNATIVES TO LABORATORY ANIMALS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 16:25:29